BOILLHEALTHCARE (01246) releases financial performance for FY2025, with a net loss attributable to owners of approximately HK$830 million, representing a six-fold increase year-on-year.

BOILLHEALTHCARE (01246) announced its annual performance for the financial year ending March 31, 2025, with revenue of 76.92 million Hong Kong dollars, a decrease of 73.03% year-on-year; the company's attributable net loss was approximately 830 million Hong Kong dollars, an increase of about 6 times year-on-year; loss per share was 61.12 Hong Kong cents. The announcement stated that the group's overall performance in the 2025 financial year was unsatisfactory, mainly due to the adverse impact of lenders choosing to auction properties instead of developing them. The group recorded a provision for net realizable value loss of approximately 299.5 million Hong Kong dollars (compared to 36.6 million Hong Kong dollars in the 2024 financial year) for properties under development in the Integrated Industrial Park project in the 2025 financial year, as well as a fair value loss of approximately 449.2 million Hong Kong dollars (compared to 188 million Hong Kong dollars in the 2024 financial year) for investment properties in the 2025 financial year.